Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

GFBiochemicals

Explore full profile

Produces levulinic acid at commercial scale directly from biomass

Paris, FranceFounded 2008Biotechnology
Valuation $50–100M Last recorded · 2022
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for GFBiochemicals and the history behind them.

About GFBiochemicals

A biochemical company that produces levulinic acid, a bio-based building block for specialty chemicals and materials, from biomass at a commercial scale.

GFBiochemicals' proprietary technology allows it to replace petroleum-based products, contributing to a more sustainable and circular economy. The company operates a production plant in Caserta, Italy, and has a presence in the Netherlands and the US through its acquisition of Segetis.

The company's mission is to end chemical pollution by providing businesses with bio-based alternatives for everyday products. GFBiochemicals recently raised €15 million in a Series A funding round to advance this mission.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Paris, France
Employees
41
Open positions
1
Dealroom signal
80.3/100
Sector
Biotechnology, Additive Manufacturing, Biofuel, Sustainable Development Goals, Climate Tech, Clean Industry, Hard Tech, observatoire greentech, observatoire industrial tech
Technology
Hardware
Business model
Manufacturing
Client focus
b2b
Investment activity
1 company, latest Feb 2016
Capital deployed
—
Preferred round
ACQUISITION

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC May 2022 $17M $66M Sparta Capital · Sofinnova Partners ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

GFBiochemicals website traffic

Latest recorded traffic for GFBiochemicals is 2.4K monthly website visits, up 203.8% over the last three months. GFBiochemicals's team grew 5.1% over the past year.

Latest monthly visits2.4K 3-month web change+203.8% 1-year team growth+5.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Other known investors1 additional known investor

  • Guillaume Sarlat
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇫🇷 France · Paris HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about GFBiochemicals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See GFBiochemicals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.